title: Hairy cell leukemia variant in a patient with chronic myeloid leukemia receiving nilotinib: sequential or coincidental?
authors.affiliation: SUNY Upstate Medical University, Syracuse, NY, USA.
authors.forename: Srivalli
authors.initials: S
authors.lastname: Gopaluni
authors.forename: Soma
authors.initials: S
authors.lastname: Sanyal
authors.forename: Alica
authors.initials: A
authors.lastname: Bair
authors.forename: Neerja
authors.initials: N
authors.lastname: Vajpayee
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001706:Biopsy; D017338:Cladribine / Q000627:therapeutic use; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007621:Karyotyping; D007943:Leukemia, Hairy Cell / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D011743:Pyrimidines; D017338:Cladribine; D011505:Protein-Tyrosine Kinases; C498826:nilotinib